|
CERVAPLEXX
I3C®
for
Cervical Dysplasia
or Abnormal Pap Smear
Cervical
Dysplasia is the abnormal growth of the
epithelial tissue on the surface of the
cervix.
CERVAPLEXX
is:
-
Natural/non-toxic
-
Counteracts effect HPV has on estrogen ratio
-
Proven in double-blind study to reduce degree of HPV-caused cervical dysplasia
-
Our dosage is the same used in the study
-
Converts estradiol to weaker metabolites that can be flushed from body
A recent study
(MS Word
document) done
between the Departments of Obstetrics and
Gynecology at both the LSU Medical
Center-Shreveport and Harvard Medical School and
the Strang Cancer Research Laboratory provided
convincing evidence that indole-3-carbinol can
reverse HPV induced CIN.1
Fifty percent
of patients enrolled in a recent study experienced
regression from either CIN II or CIN III to Normal
in just 12
weeks! (See chart). Further, all
patients in the 400mg dosage group regressed to
either CIN I or Normal.
Patient#
I3C (mg/day) |
Diagnosis2
week 1 |
Diagnosis2
week 12 |
Low-risk3
HPV |
High
risk4
HPV |
HPV
PCR
|
| 1.
placebo |
CIN II |
CIN I |
- |
pos |
pos |
| 2.
placebo |
CIN II |
CIN I |
neg |
neg |
neg |
| 3.
placebo |
CIN II |
CIN I |
neg |
pos |
- |
| 4.
placebo |
CIN III |
CIN I |
neg |
pos |
- |
| 5.
placebo |
CIN III |
CIN I |
neg |
neg |
pos |
| 6.
placebo |
CIN II |
CIN I |
neg |
neg |
- |
| 7.placebo |
CIN II |
CIN I |
neg |
neg |
- |
| 8.
placebo |
CIN III |
CIN III |
neg |
pos |
- |
| 9.
placebo |
CIN III |
CIN I |
neg |
pos |
- |
| 10.
placebo |
CIN III |
CIN III |
neg |
pos |
- |
| 11.
400 |
CIN II |
CIN I |
neg |
neg |
pos |
| 12.
400 |
CIN II |
CIN I |
neg |
pos |
pos |
| 13.
400 |
CIN III |
CIN I |
neg |
pos |
- |
| 14.
400 |
CIN II |
CIN I |
neg |
neg |
neg |
| 15.
400 |
CIN II |
normal |
neg |
neg |
pos |
| 16.
400 |
CIN III |
CIN I |
neg |
pos |
pos |
| 17.
400 |
CIN II |
normal |
neg |
neg |
pos |
| 18.
400 |
CIN III |
normal |
neg |
neg |
pos |
| 19.
400 |
CIN II |
normal |
neg |
pos |
- |
| 20.
200 |
CIN III |
CIN I |
- |
pos |
pos |
| 21.
200 |
CIN II |
normal |
neg |
pos |
- |
| 22.
200 |
CIN III |
CIN III |
neg |
neg |
neg |
| 23.
200 |
CIN II |
normal |
neg |
pos |
- |
| 24.
200 |
CIN III |
normal |
pos |
pos |
- |
| 25.
200 |
CIN II |
CIN II |
pos |
pos |
- |
| 26.
200 |
CIN II |
normal |
neg |
neg |
pos |
| 27.
200 |
CIN II |
CIN II |
neg |
pos |
- |
2Diagnosis
by biopsy 3HPV
Types 6,11,42,43,44 4HPV
Types 16,18,31,33,35,45,51,52,56
List of abbreviations:
mg/day
– milligrams per day
HPV–
human papillomavirus
CIN – cervical intraepithelial neoplastia
PCR – polymerase chain reaction
neg – negative
pos – positive
The basis for this
study was indole-3-carbinol’s efficacy against
laryngeal papillomas that are typically caused by
HPV strains 6 and 11. These are the same
strains that cause genital warts; therefore, it
may be hypothesized that the indole-3-carbinol
would also be effective against genital warts.
The proposed
mechanism of indole-3-carbinol resides in its
ability to convert estradiol to 2-OH-estrone
rather than the potentially carcinogenic
16a-OH-estrone. It is believed that HPV
alters the estrogen ratio toward 16a-OH-estrone.
The indole-3-carbinol reverses this trend.
Cervaplexx
I3C™ (30
capsules is one month’s supply) is now available
without a prescription in 400mg capsules. It
contains pure indole-3-carbinol, a natural
substance found in cruciferous vegetables (400mg
= about 1/3 head of
cabbage). There is no noted toxicity.
References
1Bell,
M.C., Crowley-Nowick, P., Bradlow, H.L., et al., 1999,
"Indole-3-carbinol in the treatment of CIN",
Society of Gynecologic Oncologists, San Francisco,
CA.
You
can contact us by mail or phone at:
Pharmogenexx
7793 West 95th Drive
Westminster, CO 80021
1-877-808-9090
email:
info@pharmogenexx.com
WE
RECOMMEND A 12 WEEK (3 BOTTLE) DOSAGE PERIOD TO
EVALUATE HOW EFFECTIVE CERVAPLEXX I3C WILL BE FOR
YOU, AS THIS WAS THE TIME FRAME OF THE STUDY.
ACCORDINGLY, WE ARE NOW OFFERING A 3 BOTTLE
TRIAL/REFILL PACK (BUY 2 BOTTLES & GET 1
BOTTLE FREE) FOR BOTH NEW AND EXISTING CUSTOMERS.
|